Glioblastoma (GBM) treatment has remained almost unchanged for more than 20 years. The
current standard of care involves surgical resection (if possible) followed by concomitant …

Glioblastoma (GBM) is a common and highly malignant primary tumor of the central nervous
system in adults. Ever more recent papers are focusing on understanding the role of the …

Simple Summary This paper summarizes the crosstalk between tumor/non-tumor cells and
other elements of the glioblastoma (GB) microenvironment. In tumor pathology, glial cells …

Glioma is the most common primary intracranial tumor and has the greatest prevalence of all
brain tumors. Treatment resistance and tumor recurrence in GBM are mostly explained by …

Simple Summary Chemokine signaling is crucial for tumorigenesis, proliferation,
angiogenesis, tumor progression and metastasis in glioblastoma. Furthermore, chemokines …

Objective Despite recent advances in diagnosis and treatment of the disease, the prognosis
of patients with glioblastoma multiforme (GBM) remains poor. While the value of molecular …

Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Background Glioblastoma (GBM) is the most common and fatal primary tumor in the central
nervous system (CNS). Due to the existence of blood–brain barrier (BBB), most therapeutics …

Background. Systemic immunity and inflammation indexes (SI) derived from blood cells
have gained increasing attention in clinical oncology as potential biomarkers that are …

Glioblastoma (GBM) is the most common and advanced form of primary malignant tumor
occurring in the adult central nervous system, and it is frequently associated with epilepsy, a …